Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers I > Headlines for InterMune Inc. > News item |
Baker Bros. Investments says it has 6% stake in InterMune
By E. Janene Geiss
Philadelphia, Jan. 26 - Investors Felix J. and Julian C. Baker of Baker Bros. Investments reported an investment of 6% in InterMune, Inc. as of Jan. 16, according to an SC 13G filing with the Securities and Exchange Commission.
That represents a passive stake of 2,431,030 shares.
Brisbane, Calif.-based InterMune is a biotechnology company focused on treatments for pulmonary, infectious and hepatic diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.